Exact Mass: 465.20860160000007
Exact Mass Matches: 465.20860160000007
Found 140 metabolites which its exact mass value is equals to given mass value 465.20860160000007
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
S9947
C29H27N3O3 (465.20523120000007)
N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-leucine, TFA
C26H31N3O3S (465.20860160000007)
2-{5-[(2,3,4,5,6-Pentamethylbenzyl)sulfanyl]-4-phenyl-4H-1,2,4-triazol-3-yl}-3-(2-pyridinyl)acrylonitrile
C28H27N5S (465.19870620000006)
Cys Cys Ile Lys
C18H35N5O5S2 (465.20795000000004)
Cys Cys Lys Ile
C18H35N5O5S2 (465.20795000000004)
Cys Cys Lys Leu
C18H35N5O5S2 (465.20795000000004)
Cys Cys Leu Lys
C18H35N5O5S2 (465.20795000000004)
Cys Ile Cys Lys
C18H35N5O5S2 (465.20795000000004)
Cys Ile Lys Cys
C18H35N5O5S2 (465.20795000000004)
Cys Lys Cys Ile
C18H35N5O5S2 (465.20795000000004)
Cys Lys Cys Leu
C18H35N5O5S2 (465.20795000000004)
Cys Lys Ile Cys
C18H35N5O5S2 (465.20795000000004)
Cys Lys Leu Cys
C18H35N5O5S2 (465.20795000000004)
Cys Leu Cys Lys
C18H35N5O5S2 (465.20795000000004)
Cys Leu Lys Cys
C18H35N5O5S2 (465.20795000000004)
Cys Arg Ser Thr
Cys Arg Thr Ser
Cys Ser Arg Thr
Cys Ser Thr Arg
Cys Thr Arg Ser
Cys Thr Ser Arg
Phe Gly Gly Trp
C24H27N5O5 (465.20120920000005)
Phe Gly Trp Gly
C24H27N5O5 (465.20120920000005)
Phe Trp Gly Gly
C24H27N5O5 (465.20120920000005)
Gly Phe Gly Trp
C24H27N5O5 (465.20120920000005)
Gly Phe Trp Gly
C24H27N5O5 (465.20120920000005)
Gly Gly Phe Trp
C24H27N5O5 (465.20120920000005)
Gly Gly Trp Phe
C24H27N5O5 (465.20120920000005)
Gly Lys Met Met
C18H35N5O5S2 (465.20795000000004)
Gly Met Lys Met
C18H35N5O5S2 (465.20795000000004)
Gly Met Met Lys
C18H35N5O5S2 (465.20795000000004)
Gly Trp Phe Gly
C24H27N5O5 (465.20120920000005)
Gly Trp Gly Phe
C24H27N5O5 (465.20120920000005)
Ile Cys Cys Lys
C18H35N5O5S2 (465.20795000000004)
Ile Cys Lys Cys
C18H35N5O5S2 (465.20795000000004)
Ile Lys Cys Cys
C18H35N5O5S2 (465.20795000000004)
Lys Cys Cys Ile
C18H35N5O5S2 (465.20795000000004)
Lys Cys Cys Leu
C18H35N5O5S2 (465.20795000000004)
Lys Cys Ile Cys
C18H35N5O5S2 (465.20795000000004)
Lys Cys Leu Cys
C18H35N5O5S2 (465.20795000000004)
Lys Gly Met Met
C18H35N5O5S2 (465.20795000000004)
Lys Ile Cys Cys
C18H35N5O5S2 (465.20795000000004)
Lys Leu Cys Cys
C18H35N5O5S2 (465.20795000000004)
Lys Met Gly Met
C18H35N5O5S2 (465.20795000000004)
Lys Met Met Gly
C18H35N5O5S2 (465.20795000000004)
Leu Cys Cys Lys
C18H35N5O5S2 (465.20795000000004)
Leu Cys Lys Cys
C18H35N5O5S2 (465.20795000000004)
Leu Lys Cys Cys
C18H35N5O5S2 (465.20795000000004)
Met Gly Lys Met
C18H35N5O5S2 (465.20795000000004)
Met Gly Met Lys
C18H35N5O5S2 (465.20795000000004)
Met Lys Gly Met
C18H35N5O5S2 (465.20795000000004)
Met Lys Met Gly
C18H35N5O5S2 (465.20795000000004)
Met Met Gly Lys
C18H35N5O5S2 (465.20795000000004)
Met Met Lys Gly
C18H35N5O5S2 (465.20795000000004)
Arg Cys Ser Thr
Arg Cys Thr Ser
Arg Ser Cys Thr
Arg Ser Thr Cys
Arg Thr Cys Ser
Arg Thr Ser Cys
Ser Cys Arg Thr
Ser Cys Thr Arg
Ser Arg Cys Thr
Ser Arg Thr Cys
Ser Thr Cys Arg
Ser Thr Arg Cys
Thr Cys Arg Ser
Thr Cys Ser Arg
Thr Arg Cys Ser
Thr Arg Ser Cys
Thr Ser Cys Arg
Thr Ser Arg Cys
Trp Phe Gly Gly
C24H27N5O5 (465.20120920000005)
Trp Gly Phe Gly
C24H27N5O5 (465.20120920000005)
Trp Gly Gly Phe
C24H27N5O5 (465.20120920000005)
4-METHOXYPHENYL 2-AMINO-3,6-DI-O-BENZYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE
CID 24906286
C26H31N3O3S (465.20860160000007)
(2R)-2-amino-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-hydroxy-1-[[(2S,4R)-4-propylpyrrolidine-2-carbonyl]amino]propyl]oxan-2-yl]sulfanylpropanoic acid
C19H35N3O8S (465.21447500000005)
N-[2-(tert-butylamino)-2-oxo-1-thiophen-2-ylethyl]-N-(2-oxolanylmethyl)-5-phenyl-1H-pyrrole-2-carboxamide
C26H31N3O3S (465.20860160000007)
5-[[2-[4-[1-(1,3-Dioxo-2-indenylidene)ethyl]-1-piperazinyl]ethylamino]methylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione
C24H27N5O5 (465.20120920000005)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H28FN3O4 (465.20637400000004)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-[(2-fluorophenyl)-oxomethyl]-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H28FN3O4 (465.20637400000004)
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
C21H31N5O5S (465.20457960000005)
1-[(1S)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C26H28FN3O4 (465.20637400000004)
1-[(1R)-2-[(4-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C26H28FN3O4 (465.20637400000004)
[(1R)-2-[(4-chlorophenyl)methyl]-1-(cyclopropylmethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
(1E,3E)-5-(3,3-dimethyloxiran-2-yl)-3-methylhexa-1,3-dienyl-quinolinone B
(3R,4R)-4,5-dihydroxy-3-methoxy-4-(4-methoxyphenyl)-6-[(E)-2-[(2S,5S)-2-methyl-5-prop-1-en-2-yloxolan-2-yl]ethenyl]-1,3-dihydroquinolin-2-one
(2S)-2-[[[4-[[(2R)-2-amino-3-mercaptopropyl]amino]-2-(1-naphthalenyl)phenyl]-oxomethyl]amino]-4-methylpentanoic acid
C26H31N3O3S (465.20860160000007)
YM-58790
YM-58790 is a potent antagonist of mAChR. YM-58790 binds M1, M2, M3 with Ki values of 28 nM, 260 nM, and 15 nM. YM-58790 exhibits potent inhibitory activity on bladder pressuer in reflexly-evoked rhythmic contraction in rats[1].
5-(acetyloxy)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
C23H31NO9 (465.19987160000005)